Tim McCarthy | LifeSci Advisors, IR |
Philip Serlin | CEO |
Mali Zeevi | CFO |
Mark Breidenbach | Oppenheimer |
John Vandermosten | Zacks |
Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2022 Conference Call. All participants are presently in a listen-only mode.
Following management's formal presentation instructions will be given for the question-and-answer session. [Operator Instructions] I would now like to turn the call over to Tim McCarthy of LifeSci Advisors.